Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vincent

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of the American Chemical Society|January 15, 2025
Viridium: A Stable Radical and Its π-DimerizationHenri-Pierre Jacquot de Rouville, Christophe Gourlaouen, David Bardelang, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in ChildrenBénédicte Neven, Jean-Sébastien Diana, Martin Castelle, et al.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
Oral Oncology|April 22, 2025
Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapyMarc Vincent N Barcelona, John Waldron, Brian O' Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapyGilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of the American Chemical Society|January 15, 2025
Viridium: A Stable Radical and Its π-DimerizationHenri-Pierre Jacquot de Rouville, Christophe Gourlaouen, David Bardelang, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in ChildrenBénédicte Neven, Jean-Sébastien Diana, Martin Castelle, et al.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
Oral Oncology|April 22, 2025
Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapyMarc Vincent N Barcelona, John Waldron, Brian O' Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapyGilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, et al.
Pageof 8